`571.272.7822
`
`
`Paper 38
`Date: March 11, 2024
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`SAMSUNG BIOEPIS CO., LTD., CELLTRION, INC., and
`BIOCON BIOLOGICS INC.,
`Petitioners,
`
`v.
`
`REGENERON PHARMACEUTICALS, INC.,
`Patent Owner.
`____________
`
`IPR2023-008841
`Patent 11,253,572 B2
`____________
`
`
`Before SUSAN L. C. MITCHELL, ROBERT A. POLLOCK, and
`RYAN H. FLAX, Administrative Patent Judges.
`
`FLAX, Administrative Patent Judge.
`
`
`
`SECOND MODIFIED SCHEDULING ORDER
`37 C.F.R. § 42.5(c)
`
`
`
`
`
`
`1 IPR2024-00260 and IPR2024-00298 were joined with IPR2023-00884.
`See Papers 31 and 33.
`
`
`
`IPR2023-00884
`Patent 11,253,572 B2
`
`
`Further to the original Scheduling Order entered November 24, 2023
`(Paper 14), this Order sets modified due dates for the parties to act after
`institution of the proceeding. Modified due dates are shown underlined in
`the following Appendix. The modified due dates include those provided in
`the parties’ stipulated changes to schedule (Paper 28) and a change in Due
`Date 8 (Oral Argument, if requested) to August 23, 2024. No other changes
`to the original Scheduling Order are ordered.
`
`
`It is hereby
`ORDERED that the schedule of the proceeding is modified as shown
`in the Appendix to this Order.
`
`
`
`2
`
`
`
`IPR2023-00884
`Patent 11,253,572 B2
`
`
`DUE DATE APPENDIX
`DUE DATE 1 ..................................................................... February 23, 2024
`Patent Owner’s response to the petition
`Patent Owner’s motion to amend the patent
`DUE DATE 2 ............................................................................ May 17, 2024
`Petitioner’s reply to Patent Owner’s response to petition
`Petitioner’s opposition to motion to amend
`DUE DATE 3 ............................................................................ June 28, 2024
`Patent Owner’s sur-reply to reply
`Patent Owner’s reply to opposition to motion to amend
`(or Patent Owner’s revised motion to amend)2
`DUE DATE 4 ............................................................................... July 8, 2024
`Request for oral argument (may not be extended by stipulation)
`DUE DATE 5 ............................................................................. July 26, 2024
`Petitioner’s sur-reply to reply to opposition to motion to amend
`Motion to exclude evidence
`DUE DATE 6 .......................................................................... August 2, 2024
`Opposition to motion to exclude
`Request for prehearing conference
`DUE DATE 7 .......................................................................... August 9, 2024
`Reply to opposition to motion to exclude
`DUE DATE 8 ........................................................................ August 23, 2024
`Oral argument (if requested)
`
`
`
`2 If Patent Owner files neither a reply to Petitioner’s opposition to the MTA
`nor a revised MTA, see Section III(C) of the Original Scheduling Order.
`
`3
`
`
`
`IPR2023-00884
`Patent 11,253,572 B2
`
`For PETITIONER SAMSUNG BIOEPIS CO., LTD.:
`
`Raymond N. Nimrod
`Matthew A. Traupman
`Landon Andrew Smith
`QUINN EMANUEL URQUHART & SULLIVAN LLP
`raynimrod@quinnemanuel.com
`matthewtraupman@quinnemanuel.com
`landonsmith@quinnemanuel.com
`qe-samsungbioepis@quinnemanuel.com.
`
`
`For PETITOINER CELLTRION, INC.:
`
`Lora Green
`Yahn Lin Chu
`GEMINI LAW LLP
`lgreen@geminilaw.com
`fchu@geminilaw.com
`
`
`For PETITIONER BIOCON BIOLOGICS INC.:
`
`Paul Molino
`Jeffrey Marx
`Neil McLaughlin
`Steven Birkos
`Deanne Mazzochi
`Thomas Ehrich
`RAKOCZY MOLINO MAZZOCHI SIWIK LLP
`paul@rmmslegal.com
`jmarx@rmmslegal.com
`nmclaughlin@rmmslegal.com
`sbirkos@rmmslegal.com
`dmazzochi@rmmslegal.com
`tehrich@rmmslegal.com
`
`
`
`4
`
`
`
`IPR2023-00884
`Patent 11,253,572 B2
`
`For PATENT OWNER:
`
`Adam R. Brausa
`Rebecca Weires
`Kira Davis
`Daralyn Durie
`MORRISON & FOERSTER LLP
`ABrausa@mofo.com
`RWeires@mofo.com
`kiradavis@mofo.com
`ddurie@mofo.com
`
`
`5
`
`